| Literature DB >> 24939606 |
Gopalan Sriram Prasath1, Sorimuthu Pillai Subramanian.
Abstract
Chronic hyperglycemia in diabetes is associated with profound changes in lipid and lipoprotein metabolism, with resultant alterations in particle distribution within lipoprotein classes. In the present study, an attempt has been made to explore the antihyperlipidemic effect of fisetin in streptozotocin-induced experimental diabetes in rats. Upon fisetin treatment to diabetic rats, the levels of blood glucose were significantly reduced with an improvement in plasma insulin. The increased levels of lipid contents in serum, hepatic, and renal tissues observed in diabetic rats were normalized upon fisetin administration. Also, the decreased levels of high-density lipoprotein cholesterol, and increased levels of low-density lipoprotein (LDL) and very LDL (VLDL) cholesterol in serum of diabetic rats were normalized. Oil Red O staining established a large number of intracellular lipid droplets accumulation in the diabetic rats. Fisetin treatment exacerbated the degree of lipid accumulation. The results of the present study exemplify the antihyperlipidemic property of the fisetin.Entities:
Keywords: Antihyperlipidemic Property; Diabetes; Fisetin; Streptozotocin
Mesh:
Substances:
Year: 2014 PMID: 24939606 DOI: 10.1002/jbt.21583
Source DB: PubMed Journal: J Biochem Mol Toxicol ISSN: 1095-6670 Impact factor: 3.642